Table 2.

Risk clinical factor analysis of the no. 10 lymph node metastasis for patients with no. 10 LN dissection.

	Univariate analysis		Multivariate analysis with RS scores		Multivariate analysis without RS scores
	OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
Age, years
≤60	1.000
>60	1.374 (0.646–2.922)	0.409
Sex
Male	1.000
Female	0.913 (0.405–2.059)	0.826
Histologic type
Differentiated	1.000
Undifferentiated	0.756 (0.361–1.586)	0.460
RS1 score	1.249 (1.169–1.334)	<0.001	1.245 (1.132–1.370)	<0.001	—	—
RS2 score	1.238 (1.158–1.323)	<0.001	1.224 (1.128–1.327)	<0.001	—	—
Tumor size, cm
≤5	1.000		1.000		1.000
>5	3.731 (1.756–7.927)	0.001	0.548 (0.161–1.862)	0.335	2.429 (1.070–5.512)	0.034
Cross-sectional part
Nongreater curvature	1.000		1		1
Greater curvature	4.011 (1.668–9.643)	0.002	2.044 (0.581–7.194)	0.265	2.840 (1.084–7.436)	0.034
cT stage
≤cT2	1.000		1.000		1.000
cT3	1.326 (0.347–5.069)	0.680	0.164 (0.022–1.202)	0.075	0.309 (0.064–1.492)	0.144
cT4	5.728 (1.623–20.209)	0.007	0.267 (0.036–1.981)	0.196	0.905 (0.194–4.211)	0.899
cN stage
cN0	1.000		1.000		1.000
cN+	17.663 (2.374–131.391)	0.005	6.944 (0.761–63.384)	0.086	16.936 (1.890–151.798)	0.011

RS, radiomics signatures.